Steele Capital Management Inc. purchased a new stake in Waters Co. (NYSE:WAT – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 625 shares of the medical instruments supplier’s stock, valued at approximately $206,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in WAT. Private Trust Co. NA lifted its position in shares of Waters by 55.3% during the third quarter. Private Trust Co. NA now owns 118 shares of the medical instruments supplier’s stock worth $32,000 after purchasing an additional 42 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC acquired a new position in Waters in the third quarter valued at approximately $33,000. Exchange Traded Concepts LLC acquired a new position in shares of Waters in the 4th quarter valued at $35,000. VisionPoint Advisory Group LLC grew its stake in shares of Waters by 300.0% during the third quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 108 shares during the period. Finally, Wetzel Investment Advisors Inc. bought a new stake in Waters in the fourth quarter valued at about $39,000. Institutional investors and hedge funds own 94.01% of the company’s stock.
Waters Trading Down 0.9 %
NYSE:WAT traded down $2.91 during trading hours on Tuesday, hitting $312.18. 37,563 shares of the company were exchanged, compared to its average volume of 403,255. The stock has a market capitalization of $18.52 billion, a price-to-earnings ratio of 29.03, a price-to-earnings-growth ratio of 6.19 and a beta of 0.92. Waters Co. has a one year low of $231.90 and a one year high of $363.80. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. The company has a fifty day simple moving average of $334.57 and a 200 day simple moving average of $308.02.
Analyst Upgrades and Downgrades
WAT has been the subject of a number of recent analyst reports. Evercore ISI upped their price target on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Stifel Nicolaus lifted their price target on shares of Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research report on Wednesday, February 7th. Finally, Barclays boosted their price target on shares of Waters from $275.00 to $300.00 and gave the company an “underweight” rating in a report on Monday, February 12th. One equities research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. Based on data from MarketBeat, Waters presently has an average rating of “Hold” and an average target price of $298.67.
Get Our Latest Analysis on Waters
Insiders Place Their Bets
In other Waters news, Director Linda Baddour sold 500 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the completion of the sale, the director now directly owns 2,250 shares of the company’s stock, valued at approximately $799,965. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.82% of the company’s stock.
Waters Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Further Reading
- Five stocks we like better than Waters
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Dividend Capture Strategy: What You Need to Know
- Hilton Demonstrates Asset Light is Right for Investors
- How to Invest in the FAANG Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.